Peginterferon alfa-2b
| Peginterferon alfa-2b | |
|---|---|
| Term | Peginterferon alfa-2b |
| Short definition | peginterferon alfa-2b - (pronounced) (Peg-IN-ter-FEER-on AL-fuh. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
peginterferon alfa-2b - (pronounced) (Peg-IN-ter-FEER-on AL-fuh. . . ) A drug used under the brand name Sylatron to prevent a melanoma from coming back after it's removed by surgery and under the brand name PEG-Intron to treat chronic hepatitis C. It's also being studied to treat other types of cancer . Peginterferon alfa-2b is a form of interferon alfa (a substance normally made by cells in the immune system) that is made in the laboratory and combined with a substance called PEG, which allows the drug to stay in the body longer. It's a type of cytokine and a type of immunomodulating agent. Also called SCH 54031
External links
- Medical encyclopedia article on Peginterferon alfa-2b
- Wikipedia's article - Peginterferon alfa-2b
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski